crystal
structur
np
reveal
rnabind
groov
locat
head
bodi
domain
exterior
surfac
np
oligom
expos
highli
access
examin
effect
conserv
posit
charg
residu
residu
rnabind
groov
np
amino
acid
residu
respect
replac
alanin
fig
form
np
express
purifi
subsequ
spr
analysi
employ
determin
interact
fulllength
np
rna
repeat
intergen
sequenc
influenza
viru
uccaaac
use
probe
spr
experi
dissoci
constant
kd
kdka
variou
np
rna
complex
obtain
kinet
analys
spr
experi
fig
ka
valu
rna
bind
similar
wt
wherea
smaller
ka
valu
wt
suggest
np
residu
like
import
rna
recognit
interact
kd
valu
rna
bind
mutant
larger
wt
mutant
largest
kd
valu
fold
wt
indic
side
chain
increas
rna
resid
time
np
tabl
addit
dissoci
constant
rna
bind
rang
much
larger
wt
fig
impli
residu
contribut
rna
bind
previous
li
et
al
report
influenza
viru
np
mutat
significantli
biolog
properti
mutant
virus
corrobor
observ
biochem
level
one
conserv
amino
acid
end
rnabind
groov
np
identifi
indispens
residu
affect
rna
explor
role
interact
rna
residu
fulllength
np
replac
amino
acid
variou
characterist
eg
f
r
via
sitedirect
mutagenesi
spr
analys
perform
measur
bind
affin
rna
purifi
wt
five
mutant
trace
spr
experi
show
bind
capac
rna
wt
mutant
np
comparison
bind
capac
protein
fig
show
bind
capac
decreas
follow
order
wt
result
emphas
import
involv
stack
interact
np
rna
kinet
associ
dissoci
constant
obtain
analys
spr
sensorgram
result
list
tabl
shown
fig
ka
valu
follow
order
wt
ka
smaller
wt
hand
kd
valu
increas
follow
order
wt
fig
kd
fold
larger
wt
taken
togeth
kd
valu
wt
five
mutant
np
decreas
follow
order
wt
fig
impli
posit
charg
also
involv
interact
np
rna
conform
wt
mutant
np
includ
without
rna
monitor
use
cd
spectroscopi
shown
figur
cd
spectra
protein
scan
nm
cd
spectra
wt
mutant
np
show
similar
wellstructur
domain
secondari
structur
well
two
neg
peak
approxim
nm
upon
addit
rna
cd
spectra
wt
mutant
np
also
show
similar
intens
approxim
nm
suggest
possess
similar
secondari
structur
composit
upon
rna
bind
compar
wt
mutant
np
without
rna
examin
thermodynam
stabil
wt
mutant
np
includ
measur
melt
temperatur
tm
purifi
wt
mutant
np
use
cd
absorb
nm
analyz
function
temperatur
fig
b
wt
np
show
thermal
denatur
midpoint
determin
cd
tabl
howev
temperatur
increas
mutant
np
unfold
rapidli
wt
np
evidenc
lower
tm
approxim
indic
contribut
significantli
structur
stabil
np
compar
wt
mutant
np
lowest
tm
valu
result
indic
delet
tyrosin
hydroxyl
would
significantli
reduc
stabil
np
suggest
tyrosin
hydroxyl
requir
proper
np
fold
also
character
stabil
structur
effect
np
bound
rna
cd
melt
analysi
fig
wt
nprna
complex
show
higher
tm
valu
mutant
nprna
complex
tabl
tm
valu
wt
np
increas
respect
upon
addit
rna
tabl
suggest
benzyl
side
chain
import
effect
stabil
nprna
complex
howev
differ
reduc
respect
upon
addit
rna
accord
previou
wt
rnp
complex
extract
influenza
viru
melt
around
replic
experi
compar
protein
heat
isol
consist
earli
studi
find
show
rna
bind
enhanc
stabil
np
within
result
would
meaning
previou
studi
report
tyrosin
residu
nucleocapsid
protein
attract
target
novel
antivir
drug
thu
virtual
screen
perform
target
np
identifi
compound
might
interact
rnabind
site
np
use
libdock
dock
program
evalu
candid
ligand
bind
np
current
studi
potenti
hit
dock
score
analyz
base
dock
result
select
seven
candid
ligand
high
score
function
assay
base
energi
calcul
molecular
dock
tabl
contain
aromat
core
stack
onto
np
addit
aromat
core
contain
hydrogen
moieti
mediat
specif
interact
np
importantli
among
potenti
hit
seven
compound
readili
avail
result
report
import
np
stabil
fold
top
hit
assay
vitro
druginduc
fluoresc
chang
experi
purifi
recombin
np
treat
top
hit
inhous
compound
collect
chang
tryptophan
fluoresc
caus
compound
use
reflect
npdrug
four
compound
significantli
decreas
np
fluoresc
select
character
fig
np
possess
multipl
rna
bind
site
compound
target
local
area
inhibit
bind
affin
rna
np
absolut
due
reason
determin
bind
affin
presenc
compound
satur
condit
protein
compound
ratio
studi
effect
four
compound
rnabind
capac
np
spr
experi
decreas
rnabind
capac
np
fig
also
evalu
kinet
associ
ka
dissoci
constant
kd
respect
dissoci
rate
constant
kd
determin
effect
four
compound
rnabind
affin
toward
np
presenc
compound
satur
condit
affin
np
bound
rna
fig
kd
nm
higher
compound
np
exhibit
weaker
rna
bind
presenc
increas
dissoci
constant
kd
valu
nm
respect
level
kd
without
drug
tabl
figur
show
np
fluoresc
decreas
increas
concentr
suggest
decreas
reflect
interact
np
molecul
result
deriv
hill
plot
analysi
assum
amount
quench
fluoresc
correspond
fraction
np
bound
fit
bind
curv
fig
result
unambigu
stoichiometri
interact
np
kd
base
dock
result
np
bound
methoxyphenyl
particip
stack
interact
side
chain
hydrogen
bond
also
form
fig
analyz
propos
interact
use
mutant
howev
observ
rel
low
fl
chang
mutant
upon
addit
fluoresc
titrat
assay
compar
wild
type
suggest
inhibit
rnabind
activ
np
directli
interact
figur
determin
interact
np
influenza
viru
assess
effect
earli
step
involv
viru
replic
np
associ
viral
rna
form
helic
nucleocapsid
first
h
perform
timeofaddit
experi
detect
viral
rna
viral
protein
synthesi
virusinfect
cell
differ
concentr
ad
cell
viru
infect
h
infect
cultur
supernat
collect
determin
viral
rna
one
viral
replic
cycl
matrix
protein
viral
rna
express
level
replic
normal
base
vehicl
control
volum
dmso
ad
shown
fig
upon
treatment
viral
rna
synthesi
influenza
cell
reduc
infect
cell
treat
similar
phenomenon
observ
dosedepend
reduc
viral
rna
synthesi
later
step
viral
cycl
assay
demonstr
inhibit
influenza
viru
replic
inhibit
concentr
viral
synthesi
reduc
next
investig
whether
inhibit
viral
rna
synthesi
virusinfect
cell
would
also
reduc
viral
protein
synthesi
express
level
np
influenza
cell
compar
viral
control
reduc
upon
treatment
later
step
viral
cycl
shown
fig
decreas
np
express
control
viral
rna
level
later
step
viral
replic
also
observ
protein
express
level
viru
infect
cell
upon
treatment
result
suggest
slow
viral
protein
synthesi
earli
stage
viral
replic
virusinfect
cell
cytotox
studi
monitor
mt
assay
fig
result
indic
cytotox
concentr
valu
overal
timeofaddit
experi
indic
exert
antivir
effect
rnabind
capac
np
viral
absorpt
stage
np
abund
rnabind
viral
protein
influenza
cell
respons
recogn
rna
form
filament
necessari
viral
rna
transcript
replic
influenza
signific
threat
human
avian
popul
understand
molecular
mechan
govern
rnp
format
may
facilit
better
control
influenza
viru
previou
xray
analys
reveal
fold
np
essenti
conserv
across
variou
influenza
viru
strain
crescentshap
structur
head
domain
bodi
domain
tail
loop
region
area
bodi
head
domain
rich
conserv
basic
residu
provid
scaffold
rna
bind
tail
loop
region
involv
oligomer
studi
investig
mechan
influenza
viru
np
bound
singlestrand
rna
use
spr
explor
effect
singl
amino
acid
substitut
hot
spot
surfac
groov
head
bodi
domain
rnaassoci
properti
np
includ
kinet
behavior
np
bound
rna
evalu
spr
associ
dissoci
phase
associ
phase
mainli
reflect
entri
rna
np
groov
wherea
dissoci
phase
measur
hydrogen
bond
environ
within
groov
accommod
rna
molecul
structur
fulllength
n
protein
taken
consider
studi
moreov
gel
filtrat
obtain
check
uniform
purifi
construct
np
addit
spr
experi
design
length
rna
oligom
length
rna
oligom
bound
one
protein
molecul
data
analysi
fit
spr
sensorgram
wild
mutant
np
bound
rna
use
langmuir
model
show
dissoci
rate
np
singlestrand
rna
increas
mutant
presenc
mutant
significantli
decreas
rate
associ
np
rna
suggest
residu
play
crucial
role
rna
bind
interestingli
kd
valu
wt
similar
find
consist
previou
studi
show
singl
amino
acid
substitut
effect
viralgenom
replic
character
interact
rna
tyrosin
mutat
phenylalanin
serin
arginin
associ
rate
ka
rna
bind
mutant
decreas
significantli
except
mutant
similar
wt
suggest
may
particip
rnabind
np
via
electrostat
interact
structur
data
avail
regard
influenza
viru
np
bind
singlestrand
rna
thu
understand
structur
interact
respons
rna
recognit
influenza
viru
np
model
structur
influenza
viru
np
rnabound
state
fig
model
indic
rnabind
groov
np
contain
togeth
clamp
rna
groov
stack
first
nucleotid
bound
rna
extend
quasihelix
current
antivir
drug
develop
treat
influenza
viru
infect
primarili
target
viral
channel
neuraminidas
howev
use
inhibitor
amantadin
rimantadin
limit
propens
drug
caus
central
nervou
system
side
effect
rapidli
increas
number
drugresist
viral
neuraminidas
inhibitor
zanamivir
oseltamivir
commonli
employ
treat
influenza
viru
infect
minim
advers
yet
recent
studi
report
influenza
viru
start
develop
resist
zanamivir
therefor
novel
antivir
strategi
requir
combat
drugresist
influenza
virus
influenza
viru
np
multifunct
rnabind
protein
associ
genom
antigenom
rna
necessari
viral
rna
transcript
recent
studi
suggest
np
repres
potenti
antiinfluenza
drug
target
mani
crucial
function
viral
life
cycl
hand
np
homolog
protein
cell
antivir
inhibitor
target
np
may
act
nonspecif
protein
cell
caus
host
cell
toxic
sever
side
effect
two
strategi
inhibit
oligomer
np
function
report
first
strategi
impair
normal
np
function
interf
equilibrium
either
enhanc
inhibit
kao
et
al
identifi
smallmolecul
compound
call
nucleozin
trigger
oligomer
np
aggreg
inhibit
nuclear
addit
su
et
al
identifi
sever
nucleozin
analogu
inhibit
replic
influenza
viru
mdck
cell
induc
sever
aggreg
np
molecul
prevent
rnp
format
product
viral
gerritz
et
al
discov
seri
influenza
replic
inhibitor
interfer
npdepend
process
via
format
higherord
np
shen
et
al
report
small
molecul
target
virtual
screen
shown
disrupt
format
np
trimer
inhibit
replic
wt
nucleozinresist
second
strategi
target
rnabind
site
contain
sever
conserv
lejal
et
al
discov
naproxen
interfer
rnabind
activ
influenza
viru
np
inhibit
viral
mutat
conserv
residu
rnabind
groov
influenza
viru
np
led
signific
decreas
rnabind
affin
subsequ
decreas
viral
accord
protein
sequenc
align
np
highli
conserv
among
strain
influenza
virus
locat
np
ligandbind
site
highli
conserv
among
influenza
virus
rnabind
groov
np
would
valid
target
broadspectrum
antivir
drug
interfer
rnabind
activ
np
competit
binder
np
may
employ
combat
strain
influenza
viru
includ
influenza
b
accord
mutat
analys
influenza
viru
np
tyrosin
residu
np
appear
interact
rna
base
via
stack
hydrogenbond
interact
play
crucial
role
protein
stabil
dock
result
suggest
sever
hit
bind
npntd
groov
use
virtual
screen
use
fluoresc
titrat
spr
assay
np
identifi
one
potenti
natur
compound
curcumin
target
influenza
viru
np
potent
interfer
rnabind
activ
also
found
could
inhibit
influenza
viru
replic
efficaci
rel
divers
previou
studi
demonstr
curcumin
exist
low
cytotox
normal
importantli
safeti
toler
nontox
curcumin
high
dose
well
establish
human
clinic
trial
therefor
ideal
point
design
new
class
inhibitor
interfer
rnabind
activ
np
formul
two
gener
guidelin
develop
influenza
viru
target
agent
first
polycycl
aromat
core
requir
enabl
stack
tyrosin
residu
np
groov
second
introduc
hydrogen
moieti
aromat
core
would
mediat
specif
interact
np
find
use
develop
new
drug
disrupt
interact
rna
influenza
viral
np
gener
fulllength
wildtyp
wt
mutant
np
encod
np
gene
amplifi
polymeras
chain
reaction
pcr
use
variou
primer
pcr
product
digest
ndei
xhoi
dna
fragment
clone
novagen
use
ligas
new
england
biolab
compet
cell
transform
result
plasmid
grown
cultur
protein
express
induc
supplement
cultur
media
mm
iptg
follow
incub
h
bacteria
harvest
centrifug
g
min
bacteri
pellet
lyse
lysi
buffer
presenc
rnase
mm
trisbuff
solut
ph
mm
nacl
mm
imidazol
solubl
protein
isol
supernat
follow
centrifug
rpm
min
remov
precipit
recombin
np
carri
ntermin
purifi
use
ninta
column
novagen
elut
gradient
rang
mm
imidazol
pure
fraction
collect
dialyz
buffer
lack
imidazol
purifi
np
greater
puriti
analyz
gel
filtrat
superdex
ge
healthcar
coomassi
blue
stain
figur
protein
concentr
determin
bradford
method
use
biorad
protein
assay
reagent
affin
associ
dissoci
np
rna
measur
use
biacor
surfac
plasmon
reson
spr
instrument
pharmacia
uppsala
sweden
equip
sensor
chip
pharmacia
repeat
sequenc
uccaaac
use
probe
spr
experi
experi
conduct
inject
np
differ
concentr
mm
tri
ph
mm
nacl
figur
calcul
stoichiometr
ratio
sm
np
rna
base
equat
rl
ru
immobil
level
rmax
ru
maximum
bind
respons
mwa
da
molecular
weight
analyt
mwl
da
molecular
weight
ligand
sm
valu
variou
np
calcul
thu
ensur
bind
stoichiometri
rna
variou
np
compar
effect
np
mutat
rnabind
activ
protein
sensorgram
fit
langmuir
model
use
biaevalu
softwar
version
determin
associ
dissoci
rate
constant
ka
kd
circular
dichroism
cd
spectra
obtain
use
cd
spectropolarimet
temperatur
control
circul
water
desir
temperatur
cell
jacket
protein
dissolv
mm
trishc
ph
mm
nacl
cd
spectra
collect
nm
bandwidth
interv
spectra
obtain
averag
five
scan
photomultipli
absorb
exceed
v
analysi
cd
spectra
normal
subtract
background
scan
buffer
alon
rna
alon
mean
residu
ellipt
calcul
base
equat
mrw
mean
residu
weight
measur
ellipt
millidegre
wavelength
l
cuvett
path
length
cm
c
protein
concentr
gml
addit
tm
determin
polynomi
fit
observ
curv
taken
temperatur
correspond
half
denatur
np
first
deriv
absorpt
respect
temperatur
dadt
melt
curv
comput
gener
use
determin
tm
small
molecul
test
primarili
obtain
inhous
collect
compound
includ
test
np
inhibitor
druginduc
fluoresc
chang
experi
final
concentr
np
ad
buffer
contain
variou
concentr
compound
sampl
incub
variou
durat
buffer
consist
mm
tri
ph
mm
nacl
tryptophan
fluoresc
measur
use
hitachi
fluoresc
spectrophotomet
equip
cuvett
light
path
excit
wavelength
nm
emiss
data
collect
nm
static
measur
record
triplic
rel
fluoresc
titrat
intens
determin
use
follow
equat
flnp
np
fluoresc
absenc
test
compound
flnpdrug
fluoresc
npcompound
complex
determin
bind
constant
test
compound
variou
np
compoundinduc
fluoresc
chang
three
separ
experi
h
addit
test
compound
averag
fit
hill
equat
use
graphpad
prism
softwar
program
san
diego
ca
follow
satur
valu
fluoresc
chang
x
drug
concentr
kd
dissoci
constant
n
hill
coeffici
exclud
inner
filter
effect
caus
ligand
correct
inner
filter
effect
bind
np
employ
follow
l
pathlength
cuvett
use
term
absorb
excit
emiss
wavelength
f
valu
correct
observ
fluoresc
intens
libdock
molecular
dock
softwar
use
screen
small
molecul
may
bind
structur
np
molecul
compris
compound
sever
drug
databank
zinc
databas
bind
pocket
np
includ
repres
set
sphere
dock
process
human
alveolar
basal
epitheli
cell
cell
atcc
access
grown
medium
gibco
madindarbi
canin
kidney
mdck
cell
atcc
access
grown
dulbecco
modifi
eagl
medium
gibco
media
supplement
fetal
bovin
serum
gibco
uml
penicillin
streptomycin
mm
lglutamin
wsn
virus
provid
clinic
virolog
laboratori
chang
gung
memori
hospit
linkou
taiwan
virus
amplifi
use
mdck
cell
viru
titer
determin
plaqu
assay
use
mdck
cell
timeofaddit
experi
cell
infect
wsn
moi
incub
medium
time
point
infect
ad
differ
concentr
cell
rins
pb
remov
drug
cultur
medium
cell
lysat
appli
detect
viral
rna
viral
protein
h
postinfect
total
cell
seed
sixwel
plate
allow
reach
confluenc
challeng
viru
moi
total
rna
extract
cell
use
trizol
reagent
invitrogen
carlsbad
ca
usa
follow
phenolchloroform
extract
isopropanol
precipit
rna
pellet
wash
dri
dissolv
ml
rnasefre
water
protocol
rtpcr
amplif
qpcr
describ
hsu
et
cell
lysat
collect
lyse
lysi
buffer
mm
nacl
mm
trisbas
ph
detect
target
protein
protein
sampl
buffer
subject
sdspage
electroblot
onto
hybond
ecl
membran
amersham
block
incub
antibodi
done
use
tween
trisbuff
western
blot
membran
incub
dilut
antinp
rabbit
polyclon
ab
kindli
provid
dr
shin
ru
shih
research
center
emerg
viral
infecti
chang
gung
univers
cell
cytotox
inhibitor
determin
mt
assay
cell
grown
cellswel
plate
h
medium
replac
contain
serial
dilut
compound
viru
infect
h
infect
cell
incub
h
cultur
medium
remov
ad
includ
mt
pm
mixtur
solut
plate
incub
min
mt
pm
purchas
sigma
prepar
pb
phosphat
buffer
salin
identifi
microtit
plate
ml
reagent
contain
mt
pm
ratio
mix
immedi
serumfre
dmem
drug
concentr
perform
four
repeat
optic
densiti
measur
multiwel
spectrophotomet
elisa
reader
crystal
structur
influenza
viru
np
protein
data
bank
code
lack
defin
tertiari
structur
region
amino
acid
residu
swissmodel
program
use
model
complet
structur
np
use
complet
structur
np
templat
construct
plausibl
npssrna
complex
use
molecular
model
program
discoveri
studio
rna
forc
field
paramet
parkinson
et
al
qualiti
model
geometri
evalu
use
rm
deriv
bond
length
bond
angl
qualiti
model
structur
test
cite
articl
liu
cl
et
al
use
mutagenesi
explor
conserv
residu
rnabind
groov
influenza
viru
nucleoprotein
antivir
drug
develop
sci
rep
doi
